Recombinant Newcastle disease virus expressing human IFN-λ1 (rL-hIFN-λ1)-induced apoptosis of A549 cells is connected to endoplasmic reticulum stress pathways
/in Dendritic Cells, International Publications, NSCLC /von 2018-09-23 / Thorac Cancer 2018 Nov;9(11):1437-1452Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOS
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2018-09-07 / Front Immunol 2018;9:2034Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4 T-lymphocyte counts
/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von 2018-08-29 / CNS Oncol 2018 07;7(3):CNS22Further clinical advancement of dendritic cell vaccination against ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2018-08-23 / Ann Res Hosp 2018 Aug;2Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-08-22 / Cancer Immunol. Immunother. 2018 Nov;67(11):1777-1788Comparative effect of immunotherapy and standard therapy in patients with high grade glioma: a meta-analysis of published clinical trials
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-08-07 / Sci Rep 2018 Aug;8(1):11800Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial)
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2018-08-05 / BMJ Open 2018 08;8(8):e021701Immunotherapeutic strategies for treatment of hepatocellular carcinoma with antigen-loaded dendritic cells: in vivo study
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2018-07-30 / Clin. Exp. Med. 2018 Nov;18(4):535-546Low-dose cyclophosphamide depletes circulating naïve and activated regulatory T cells in malignant pleural mesothelioma patients synergistically treated with dendritic cell-based immunotherapy
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2018-07-30 / Oncoimmunology 2018;7(12):e1474318IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de